ArticleJournal of virology1995
cis-Acting components of human papillomavirus (HPV) DNA replication: linker substitution analysis of the HPV type 11 origin.
Article in Journal of virology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 44 citations in OpenAlex.
- The polymerase milieu of human papillomavirus.Journal of virology · 2026Review
- Inhibition of DNA replication of human papillomavirus by using zinc finger-single-chain FokI dimer hybrid.Molecular biotechnology · 2014Article
- The E1 proteins.Virology · 2013Review
- Gene- and protein-delivered zinc finger-staphylococcal nuclease hybrid for inhibition of DNA replication of human papillomavirus.PloS one · 2013Article
- Engagement of the ATR-dependent DNA damage response at the human papillomavirus 18 replication centers during the initial amplification.Journal of virology · 2013Article
- Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses.PLoS pathogens · 2009Article
- Replication and partitioning of papillomavirus genomes.Advances in virus research · 2008Review
- Genomic instability of the host cell induced by the human papillomavirus replication machinery.The EMBO journal · 2007Article
- Inhibition of DNA replication of human papillomavirus by artificial zinc finger proteins.Journal of virology · 2006Article
- The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2.Genes & development · 2004Article
- The papillomavirus E8-E2C protein represses DNA replication from extrachromosomal origins.Molecular and cellular biology · 2003Article
- Genetic analysis of cis regulatory elements within the 5' region of the human papillomavirus type 31 upstream regulatory region during different stages of the viral life cycle.Journal of virology · 2002Article
- Orientation of a novel DNA binding site affects human papillomavirus-mediated transcription and replication.Journal of virology · 2001Article
- The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element.Journal of virology · 2000Article
- Transcription factor YY1 represses cell-free replication from human papillomavirus origins.Journal of virology · 1998Article
- Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31.Journal of virology · 1998Article
- Analysis of the internal replication sequence indicates that there are three elements required for efficient replication of minute virus of mice minigenomes.Journal of virology · 1997Article
- Bovine papillomavirus type 1 DNA replication: the transcriptional activator E2 acts in vitro as a specificity factor.Journal of virology · 1997Article
- Genetic analysis of the activation domain of bovine papillomavirus protein E2: its role in transcription and replication.Journal of virology · 1996Article
- Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator.The EMBO journal · 1996Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Papillomavirus DNA replication requires the viral trans-acting factors E1 and E2 in addition to the host cell's general replication machinery. The origins of DNA replication in bovine and human papillomavirus genomes have been localized to a specific part of the upstream regulatory region (URR) which includes recognition sites for E1 and E2 proteins. To fine map cis-acting elements influencing human papillomavirus type 11 (HPV-11) DNA replication and to determine the relative contributions of such sites, we engineered consecutive linker substitution mutations across a region of 158 bp in the HPV-11 origin and tested mutant origins for replication function in a cell-based transient replication assay. Our results both confirm and extend the findings of others. E2 binding sites are the major cis components of HPV-11 DNA replication, and there is evidence for synergy between these sites. Differential capacity of the three E2 binding sites within the origin to affect replication may be attributed, at least in part, to context. At least one E2 binding site is essential for replication. The imperfect AT-rich palindrome of the E1 helicase binding site is not essential since replication occurs even in the absence of this sequence. However, replication is enhanced by the presence of the palindromic sequence in the HPV-11 origin. Sequence components adjacent to the E1 and E2 binding sites, comprising AT-rich and purine-rich elements and the consensus TATA box sequence, probably contribute to the overall efficiency of replication, though they are nonessential. None of the other cis elements of the HPV-11 origin region analyzed seems to influence replication significantly in the system described. The HPV-11 origin of DNA replication therefore differs from those of the other papovaviruses, simian virus 40 and polyomavirus, inasmuch as an intact helicase binding site and adjacent AT-rich components, while influential, are not absolutely essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.